Most dollars spent on top-selling orphan drugs don't go to treat people with rare diseases

Retrieved on: 2021-03-01 21:00:00

Tags for this article:

Health sciences

Health

Life Sciences

Pharmaceutical industry

Pharmaceuticals policy

Drug pricing

Food and Drug Administration

Click the tags to see associated articles and topics

Most dollars spent on top-selling orphan drugs don't go to treat people with rare diseases. View article details on hiswai:

Excerpt

Meister Child Health Evaluation and Research Center and the U-M Institute for Healthcare Policy and Innovation. In addition to Chua, the new paper's ...

Article found on: www.eurekalert.org

View Original Article